Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/SCLP stock hub

AIM/SCLP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/SCLPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

176.4M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/SCLP

In the news

Latest news · AIM/SCLP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC-212

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/SCLP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

GBP

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	60
Employees Change	-1%
Employees Change Percent	-1.64
Enterprise value	GBX 184M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00B63D3314
Last refreshed	2026-05-10
Market cap	GBX 176.4M
Price	GBX 17.4
Price currency	GBX
Rev Per Employee	78,516.67x
Sector	Healthcare
Sic	2836
Symbol	aim/SCLP
Website	https://www.scancell.co.uk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.12%
EV Earnings	-33.39x
EV/FCF	-21.24x
EV/Sales	39.06x
FCF yield	-4.91%
P/B ratio	-21.07x
P/S ratio	37.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-283.34%
EBITDA Margin	-275.16%
Gross margin	94.95%
Gross Profit	GBX 4.5M
Gross Profit Growth	0%
Gross Profit Growth5 Y	-1.18%
Net Income	GBX -5.5M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-175.63%
Profit Margin	-116.98%
Profit Per Employee	GBX -91,850
ROA	-52.17
Roa5y	-29.93
ROCE	159.4
ROIC	-212

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.14%
Cagr15y	6.16%
Cagr1y	78.53%
Cagr3y	4.51%
Cagr5y	-3.91%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x
Revenue Growth5 Y	-2.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.29
Assets	GBX 15.4M
Cash	GBX 8.6M
Current Assets	GBX 13.3M
Current Liabilities	GBX 23.7M
Debt	GBX 16.2M
Debt FCF	GBX -1.87
Equity	GBX -8.4M
Interest Coverage	-7.02
Liabilities	GBX 23.7M
Long Term Assets	GBX 2.1M
Long Term Liabilities	GBX 0
Net Cash	GBX -7.6M
Net Cash By Market Cap	GBX -4.31
Tangible Book Value	GBX -10M
Tangible Book Value Per Share	GBX -0.01
WACC	7.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.56
Net Working Capital	GBX -2.9M
Quick ratio	0.56
Working Capital	GBX -10.5M
Working Capital Turnover	GBX -0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	12%
1Y total return	78.46%
200-day SMA	11.14
3Y total return	14.14%
50-day SMA	12.93
50-day SMA vs 200-day SMA	50over200
5Y total return	-18.09%
All Time High	65.16
All Time High Change	-73.3%
All Time High Date	2012-10-08
All Time Low	0.11
All Time Low Change	15,463.51%
All Time Low Date	2017-11-20
ATR	0.88
Beta	0.57
Beta1y	1.02
Beta2y	0.24
Ch YTD	75.76
High	17.5
High52	17.5
High52 Date	2026-05-08
High52ch	-0.57%
Low	16.5
Low52	7.86
Low52 Date	2025-09-11
Low52ch	121.49%
Ma50ch	34.6%
Price vs 200-day SMA	56.15%
RSI	78.46
RSI Monthly	62.56
RSI Weekly	73.81
Sharpe ratio	1.3x
Sortino ratio	2.29
Total Return	-11.62%
Tr YTD	75.76
Tr15y	145.25%
Tr1m	51.3%
Tr1w	15.23%
Tr3m	33.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -13.3M
Operating margin	-283.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	582,706,918%
Net Borrowing	-1,419,000
Shares Insiders	0.26%
Shares Institutions	46.43%
Shares Out	1,037,781,403
Shares Qo Q	18.61%
Shares Yo Y	11.62%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -10.7M
Average Volume	2,136,453.95x
Bv Per Share	-0.01
CAPEX	GBX -14,000
Ch10y	9.61
Ch15y	140
Ch1m	51.3
Ch1w	15.23
Ch1y	78.46
Ch3m	33.85
Ch3y	14.1
Ch5y	-18.12
Ch6m	74
Change	5.45%
Change From Open	2.47
Close	16.5
Days Gap	2.91
Depreciation Amortization	385,000
Dollar Volume	28,281,699
Earnings Date	2026-05-15
EBIT	GBX -13.3M
EBITDA	GBX -13M
EPS	GBX -0.01
F Score	1
FCF	GBX -8.7M
FCF EV Yield	-4.71x
FCF Per Share	GBX -0.01
Financing CF	9,142,000
Fiscal Year End	April
Founded	1,996
Income Tax	GBX -2.8M
Investing CF	-1,058,000
Is Primary Listing	1
Last Earnings Date	2026-01-29
Last Report Date	2025-10-31
Last Split Date	2011-07-26
Last Split Type	Forward
Ma150	11.53
Ma150ch	50.91%
Ma20	13.91
Ma20ch	25.06%
Net CF	-529,000
Next Earnings Date	2026-05-15
Open	16.98
Position In Range	90
Ppne	491,000
Price Date	2026-05-08
Relative Volume	0.79x
Revenue	4,711,000x
SBC By Revenue	42.5x
Share Based Comp	2,002,000
Tax By Revenue	-58.65x
Tr6m	74%
Volume	1,625,385
Z Score	-10.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/SCLP pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/SCLP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/SCLP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.4%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+11.6%

Negative means the company is buying back shares.

Technical

AIM/SCLP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

78.5

Above 70: short-term overbought

Price vs 200-day MA

+56.2%

50/200-day relationship not available

Beta (5Y)

0.57

Less volatile than the market

Sharpe ratio

1.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/SCLP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/SCLP stock rating?

aim/SCLP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/SCLP analysis?

The full report lives at /stocks/aim/SCLP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/SCLP?

The latest report frames aim/SCLP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/SCLP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.